Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Daniel Hargboel Madsen
Has grant
Professor
Research Interests
Explore related searches
Recent Grants
Grant: Open
SLAM-CHECK - Development of a next-generation checkpoint inhibitor for cancer treatment
Open Date: 2026-01-01
Close Date: 2027-01-01
Grant: Open
Repurposing of the beta-blocker propranolol for cancer treatment
Open Date: 2026-01-01
Close Date: 2029-01-01
Grant: Open
TACTIC - Targeted Adaptation of Cells to Tumor-Induced Immune Challenges
Open Date: 2025-01-01
Close Date: 2028-01-01
Grant: Close
Forbedring af lungekræftbehandling ved øget forståelse af resistensmekanismer
Open Date: 2024-01-01
Close Date: 2024-01-01
Grant: Close
Development of a next-generation checkpoint inhibitor for cancer treatment
Open Date: 2024-01-01
Close Date: 2024-01-01
Articles (12)
Year:
2025
Year:
2025
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Collaborators (14)
Astrid Zedlitz Johansen
department of oncology copenhagen university hospital–herlev and gentofte herlev denmark
Lars Grøntved
University of Southern Denmark
Kirstine Sandal Nørregaard
Københavns Universitet
Marie Kveiborg
Group Leader
University of Copenhagen Biotech Research and Innovation Centre
Özcan Met
Københavns Universitet
Nicolai Grønne Jørgensen
Københavns Universitet
Anne Mette Askehøj Rømer
PhD Student
University of Southern Denmark
Christina Ankjærgaard
Technical University of Denmark
Christian Beltoft Brøchner
Københavns Universitet
Lars Engelholm
Københavns Universitet
Mads Hald Andersen
Professor, dr.techn., dr. Med, Director
National Center for Cancer Immune Therapy, CCIT-DK
Niels Behrendt
Professor
University of Copenhagen
Stefano Ugel
Associate Professor
University of Verona
Ole N. Jensen
University of Southern Denmark
Make your next move.
Prepare your application
Review drafts before you send them.